Nickolas Poulos, DO is a native of Florida. He received an undergraduate degree in Biology at the University of Miami. After graduation he proudly served in the US Army for four years as an emergency health care specialist. He then went on to pursue a career in medicine and attended Nova Southeastern University. He completed a Traditional Rotating Internship and is currently a dermatology resident in his third year at Larkin Community Hospital. After graduating he plans on opening a practice in Colorado.
Medical Dermatology Update
This lecture will introduce basic approaches to complex medical dermatology with specific diseases being reviewed.
- How to manage and identify complex medical dermatology cases
- Learn various presentations and variations of skin conditions
- New treatments on the horizon
- Review histopathology of unique and difficult cases
- Explore different treatment options for difficult to manage cases
- Diagnosis and pathophysiology of select diseases
- New advances in dermatologic treatment
- Availability of new medication(s) and indication(s)
- Advances in medical knowledge
- New methods of diagnosis or treatment
- Development of new technology
- Legislative, regulatory, or organizational changes effecting patient care
- Bolognia, Jean L., et al. “Dermatology” Section 4, Chapter 20, pg 323-332. Mosby Elsevier. 2008.
- Chong, Huey Ti, et al. “Cost-Effectiveness analysis of HLA-B*58”. Pharmacogenetics and Genomics, 2017, p. 1, doi:10.1097/fpc.0000000000000319.
- Bolognia 2nd edition, North, Paula E, Kincannon, Jay. Section 18, Chapter 114, pg. 1788.
- Weedon’s Skin Pathology, Weedon, David. Section 7, Chapter 38, pg. 920.
- Bolognia 2nd Edition – Section 7/42, pg. 583.
- Carter, A., Orgega-Loayza, AG., Barrett, J., Nunley, J., “Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin: a multidisciplinary approach”. Clinical and Experimental Dermatology. Doi:10.1111/ced.12729.
- Speeckaert MM, Devreese KMJ, Vanholder RC, Dhondt A. “Fondaparinux as an alternative to vitamin K antagonists in haemodialysis patients”. Nephrology Dialysis Transplantation. 2013;28(12):3090-3095. Doi:10.1093/ndt/gft293.
Core Competencies: 1, 2, 3, 4, 6, 7
Disclosures: No disclosures provided by speaker